Skip to content

A survey of effect of Transcranial direct current stimulation on reduction of symptoms in poor-responder major depression patients

A survey of effect of Transcranial direct current stimulation on reduction of symptoms in poor-responder major depression patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015100321965N2
Enrollment
51
Registered
2015-12-24
Start date
2015-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depression. A disorder characterized by repeated episodes of depression, the current episode being severe without psychotic symptoms, as in F32.2, and without any history of mania.

Interventions

The method will be designed a Quasi experimental single group (without control group) before and after study. The patients will be treated by 10 sessions with 30 minutes TDCS..
Treatment - Other
The method will be designed a Quasi experimental single group (without control group) before and after study. The patients will be treated by 10 sessions with 30 minutes TDCS.

Sponsors

Research and Technology assistance(Vice chanceller for research) ,Guilan University Of Medical Scien
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 77 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Non-psychotic major depression treatment-resistant, Test score of 29 or greater on Beck-II Depression Questionnaire, anti depressants ( NSR, SSRI), Benzodiazepines and antipsychotic drugs consumption at least 4 weeks before the study, absence of neurological disease, Without any complication; Exclusion criteria: pregnancy, any kind of drug or substance dependency in the last 6 months, any kind of major co morbidity Psychiatric Disorders(like Schizophrenia, Bipolar and …., any kind of Metal prosthesis in the body.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
?Depression. Timepoint: 1,5, 10 treatment. Method of measurement: Beck-II Depression Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Kiomars Najafi

Guilan University Of Medical Sciences

Kkiomars@yahoo.com K-nagafi@gums.ac.ir+98 13 3366 6268

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026